|
1
|
Ghariani I, Braham N, Hassine M and Kortas
M: Myelodysplastic syndrome classification. Ann Biol Clin.
71:139–144. 2013.In French.
|
|
2
|
Jädersten M and Hellström-Lindberg E: New
clues to the molecular pathogenesis of myelodysplastic syndromes.
Exp Cell Res. 316:1390–1396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Visconte V, Selleri C, Maciejewski JP and
Tiu RV: Molecular pathogenesis of myelodysplastic syndromes. Transl
Med UniSa. 8:19–30. 2014.PubMed/NCBI
|
|
4
|
DiMartino JF, Lacayo NJ, Varadi M, Li L,
Saraiya C, Ravindranath Y, Yu R, Sikic BI, Raimondi SC and Dahl GV:
Low or absent SPARC expression in acute myeloid leukemia with MLL
rearrangements is associated with sensitivity to growth inhibition
by exogenous SPARC protein. Leukemia. 20:426–432. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rotllant J, Liu D, Yan YL, Postlethwait
JH, Westerfield M and Du SJ: Sparc (Osteonectin) functions in
morphogenesis of the pharyngeal skeleton and inner ear. Matrix
Biol. 27:561–572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsiao YH, Lien HC, Hwa HL, Kuo WH, Chang
KJ and Hsieh FJ: SPARC (osteonectin) in breast tumors of different
histologic types and its role in the outcome of invasive ductal
carcinoma. Breast J. 16:305–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wiese AH, Auer J, Lassmann S, Nährig J,
Rosenberg R, Höfler H, Rüger R and Werner M: Identification of gene
signatures for invasive colorectal tumor cells. Cancer Detect Prev.
31:282–295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Said N, Frierson HF Jr, Chernauskas D,
Conaway M, Motamed K and Theodorescu D: The role of SPARC in the
TRAMP model of prostate carcinogenesis and progression. Oncogene.
28:3487–3498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Isler SG, Ludwig CU, Chiquet-Ehrismann R
and Schenk S: Evidence for transcriptional repression of SPARC-like
1, a gene downregulated in human lung tumors. Int J Oncol.
25:1073–1079. 2004.PubMed/NCBI
|
|
10
|
Boultwood J, Pellagatti A, Cattan H,
Lawrie CH, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M,
Killick S, Fidler C, et al: Gene expression profiling of
CD34+ cells in patients with the 5q-syndrome. Br J
Haematol. 139:578–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duong VH, Komrokji RS and List AF:
Efficacy and safety of lenalidomide in patients with
myelodysplastic syndrome with chromosome 5q deletion. Ther Adv
Hematol. 3:105–116. 2012. View Article : Google Scholar
|
|
12
|
Koren-Michowitz M, Maayan H, Apel A,
Shem-Tov N, Yerushalmi R, Volchek Y, Avigdor A, Shimoni A and
Nagler A: Salvage therapy with ARA-C and gemtuzumab ozogamicin in
AML patients relapsing after stem cell transplantation. Ann
Hematol. 94:375–378. 2015. View Article : Google Scholar
|
|
13
|
Strauss C, Endimiani A and Perreten V: A
novel universal DNA labeling and amplification system for rapid
microarray-based detection of 117 antibiotic resistance genes in
Gram-positive bacteria. J Microbiol Methods. 108:25–30. 2015.
View Article : Google Scholar
|
|
14
|
Prieto C, Risueño A, Fontanillo C and De
las Rivas J: Human gene coexpression landscape: Confident network
derived from tissue transcriptomic profiles. PLoS One. 3:e39112008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jing Z, Liu Y, Dong M, Hu S and Huang S:
Identification of the DNA binding element of the human ZNF333
protein. J Biochem Mol Biol. 37:663–670. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slavin D, Sapin V, López-Diaz F, Jacquemin
P, Koritschoner N, Dastugue B, Davidson I, Chatton B and Bocco JL:
The Krüppel-like core promoter binding protein gene is primarily
expressed in placenta during mouse development. Biol Reprod.
61:1586–1591. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alachkar H, Santhanam R, Maharry K,
Metzeler KH, Huang X, Kohlschmidt J, Mendler JH, Benito JM, Hickey
C, Neviani P, et al: SPARC promotes leukemic cell growth and
predicts acute myeloid leukemia outcome. J Clin Invest.
124:1512–1524. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pellagatti A, Jädersten M, Forsblom AM,
Cattan H, Christensson B, Emanuelsson EK, Merup M, Nilsson L,
Samuelsson J, Sander B, et al: Lenalidomide inhibits the malignant
clone and up-regulates the SPARC gene mapping to the commonly
deleted region in 5q-syndrome patients. Proc Natl Acad Sci USA.
104:11406–11411. 2007. View Article : Google Scholar
|
|
19
|
Kimura S, Kuramoto K, Homan J, Naruoka H,
Ego T, Nogawa M, Sugahara S and Naito H: Antiproliferative and
antitumor effects of azacitidine against the human myelodysplastic
syndrome cell line SKM-1. Anticancer Res. 32:795–798.
2012.PubMed/NCBI
|
|
20
|
Nakagawa T and Matozaki S: The SKM-1
leukemic cell line established from a patient with progression to
myelomonocytic leukemia in myelodysplastic syndrome
(MDS)-contribution to better understanding of MDS. Leuk Lymphoma.
17:335–339. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nian Q, Xiao Q, Wang L, Luo J, Chen LP,
Yang ZS and Liu L: SPARC silencing inhibits the growth of acute
myeloid leukemia transformed from myelodysplastic syndrome via
induction of cell cycle arrest and apoptosis. Int J Mol Med.
33:856–862. 2014.PubMed/NCBI
|
|
22
|
Lu J, Li M, Zhang R, Hu C, Wang C, Jiang
F, Yu W, Qin W, Tang S and Jia W: A common genetic variant of
FCN3/CD164L2 is associated with essential hypertension in a Chinese
population. Clin Exp Hypertens. 34:377–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dondelinger Y, Declercq W, Montessuit S,
Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA,
Marquis RW, et al: MLKL compromises plasma membrane integrity by
binding to phosphatidylinositol phosphates. Cell Rep. 7:971–981.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mansouri S, Barde S, Ortsäter H, Eweida M,
Darsalia V, Langel U, Sjöholm A, Hökfelt T and Patrone C: GalR3
activation promotes adult neural stem cell survival in response to
a diabetic milieu. J Neurochem. 127:209–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Close P, Gillard M, Ladang A, Jiang Z,
Papuga J, Hawkes N, Nguyen L, Chapelle JP, Bouillenne F, Svejstrup
J, et al: DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity
and migration of melanoma cells as subunits of Elongator. J Biol
Chem. 287:32535–32545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meyer JA, Wang J, Hogan LE, Yang JJ,
Dandekar S, Patel JP, Tang Z, Zumbo P, Li S, Zavadil J, et al:
Relapse-specific mutations in NT5C2 in childhood acute
lymphoblastic leukemia. Nat Genet. 45:290–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hubalek M, Buchner H, Mörtl MG, Schlembach
D, Huppertz B, Firulovic B, Köhler W, Hafner E, Dieplinger B, Wildt
L, et al: The vitamin E-binding protein afamin increases in
maternal serum during pregnancy. Clin Chim Acta. 434:41–47. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson EJ: Age-related macular
degeneration and antioxidant vitamins: Recent findings. Curr Opin
Clin Nutr Metab Care. 13:28–33. 2010. View Article : Google Scholar
|
|
29
|
Gill G: Regulation of the initiation of
eukaryotic transcription. Essays Biochem. 37:33–43. 2001.
View Article : Google Scholar
|
|
30
|
Quek XC, Thomson DW, Maag JL, Bartonicek
N, Signal B, Clark MB, Gloss BS and Dinger ME: lncRNAdb v2.0:
Expanding the reference database for functional long noncoding
RNAs. Nucleic Acids Res. 43(Database issue): D168–D173. 2015.
View Article : Google Scholar :
|
|
31
|
Zou Y, Wang Q, Li B, Xie B and Wang W:
Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in
glioma. Mol Med Rep. 10:411–416. 2014.PubMed/NCBI
|
|
32
|
Cowley AW Jr, Moreno C, Jacob HJ, Peterson
CB, Stingo FC, Ahn KW, Liu P, Vannucci M, Laud PW, Reddy P, et al:
Characterization of biological pathways associated with a 1.37 Mbp
genomic region protective of hypertension in Dahl S rats. Physiol
Genomics. 46:398–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cubillos-Rojas M, Amair-Pinedo F,
Peiró-Jordán R, Bartrons R, Ventura F and Rosa JL: The E3 ubiquitin
protein ligase HERC2 modulates the activity of tumor protein p53 by
regulating its oligomerization. J Biol Chem. 289:14782–14795. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liebermann DA, Hoffman B and Vesely D: p53
induced growth arrest versus apoptosis and its modulation by
survival cytokines. Cell Cycle. 6:166–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boultwood J, Pellagatti A and Wainscoat
JS: Haploinsufficiency of ribosomal proteins and p53 activation in
anemia: Diamond-Blackfan anemia and the 5q-syndrome. Adv Biol
Regul. 52:196–203. 2012. View Article : Google Scholar
|
|
36
|
Goldberg L, Tijssen MR, Birger Y, Hannah
RL, Kinston SJ, Schütte J, Beck D, Knezevic K, Schiby G,
Jacob-Hirsch J, et al: Genome-scale expression and transcription
factor binding profiles reveal therapeutic targets in transgenic
ERG myeloid leukemia. Blood. 122:2694–2703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Linden F, Domschke G, Erbel C, Akhavanpoor
M, Katus HA and Gleissner CA: Inflammatory therapeutic targets in
coronary atherosclerosis-from molecular biology to clinical
application. Front Physiol. 5:4552014. View Article : Google Scholar : PubMed/NCBI
|
